Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Operations Statements (unaudited)

v3.20.1
Condensed Consolidated Operations Statements (unaudited) - USD ($)
3 Months Ended 9 Months Ended
Jan. 31, 2020
Jan. 31, 2019
Jan. 31, 2020
Jan. 31, 2019
Income Statement [Abstract]        
Revenues $ 34,538 $ 34,538
Cost of goods sold 16,234 16,234
Gross Margin 18,304 18,304
Operating Expenses        
Research and development 138,465 107,246 400,884 258,636
General and administrative expenses 318,458 219,805 593,662 372,745
Total operating expenses 456,923 327,051 994,546 631,381
Operating loss (438,619) (327,051) (976,242) (631,381)
Provision for income taxes
Net loss $ (438,619) $ (327,051) $ (976,242) $ (631,381)
Loss per share - basic and diluted $ 0.02 $ 1.82 $ 0.08 $ 3.56
Weighted average shares outstanding - basic and diluted 17,732,298 179,293 11,556,950 177,440